Zusammenfassung
Delir ist die häufigste Form einer zerebralen Dysfunktion bei Patienten auf der Intensivstation und ein medizinischer Notfall, der vermieden oder zeitnah diagnostiziert und therapiert werden muss. Nach heutigem Kenntnisstand scheint die Entwicklung eines Delirs durch ein Zusammenspiel von erhöhter Vulnerabilität (Prädisposition) und der gleichzeitigen Exposition gegenüber delirogenen Faktoren bedingt zu sein. Da in der klinischen Routine ein Delir häufig übersehen wird, sollte engmaschig ein Delirscreening erfolgen. Wegen der engen Verknüpfung zwischen Delir, Agitation und Schmerz muss analog zum Delirscreening mindestens alle 8 h zusätzlich eine Evaluation der Sedierung und der Analgesie erfolgen. In der Prävention und Therapie des Delirs wird nach heutigem Kenntnisstand ein multifaktorielles und multiprofessionelles Vorgehen favorisiert. Hierbei hat die nichtmedikamentöse Intervention durch Frühmobilisation, Reorientierung, Schlafverbesserung, adäquate Schmerztherapie und Vermeidung einer Polypharmazie einen hohen Stellenwert. In der symptomorientierten medikamentösen Delirtherapie finden, in Abhängigkeit von dem klinischen Bild, unterschiedliche Substanzen Anwendung. Um diese diagnostischen und therapeutischen Ziele zu erreichen, ist ein interdisziplinäres Behandlungsteam, bestehend aus Intensivpflege, Intensivärzten, Stationsapothekern, Physiotherapeuten, Ernährungsspezialisten und Psychiatern notwendig, um den Anforderungen des Patienten und deren Angehörigen gerecht zu werden.
Abstract
Delirium is the most common form of cerebral dysfunction in intensive care patients and is a medical emergency that must be avoided or promptly diagnosed and treated. According to current knowledge the development of delirium seems to be caused by an interplay between increased vulnerability (predisposition) and simultaneous exposure to delirogenic factors. Since delirium is often overlooked in the clinical routine, a continuous screening for delirium should be performed. Due to the close connection between delirium, agitation and pain, sedation and analgesia must be evaluated at least every 8 h analogous to delirium screening. According to current knowledge, a multifactorial and multiprofessional approach is favored in the prevention and treatment of delirium. Non-pharmaceutical interventions through early mobilization, reorientation, sleep improvement, adequate pain therapy and avoidance of polypharmacy are of great importance. Depending on the clinical picture, different substances are used in symptom-oriented drug treatment of delirium. In order to achieve these diagnostic and therapeutic goals, an interdisciplinary treatment team consisting of intensive care, intensive care physicians, ward pharmacists, physiotherapists, nutrition specialists and psychiatrists is necessary in order to meet the requirements of the patient and their relatives.
Change history
28 November 2018
Erratum zu:
Anaesthesist 2018
https://doi.org/10.1007/s00101-018-0497-3
Im ursprünglich veröffentlichten Beitrag wird im Abschnitt „Delirprävention – Medikamentöse Prophylaxe“ und im Abschnitt „Delirtherapie“ eine falsche Dosierungsangabe für Dexmedetomidim zur Delirprävention und bei beatmeten Delirpatienten gemacht, die wegen einer Agitation nicht adäquat von der Beatmung entwöhnt werden …
Literatur
Brummel NE, Girard TD (2013) Preventing delirium in the intensive care unit. Crit Care Clin 29:51–65
Ely EW, Inouye SK, Bernard GR et al (2001) Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 286:2703–2710
Adamis D, Rooney S, Meagher D et al (2015) A comparison of delirium diagnosis in elderly medical inpatients using the CAM, DRS-R98, DSM-IV and DSM-5 criteria. Int Psychogeriatr 27:883–889
Maldonado JR (2017) Delirium and pathophysiology: An updated hypothesis of the etiology of acute brain failure. Int J Geriatr Psychiatry. https://doi.org/10.1002/gps.4823
Luetz A, Heymann A, Radtke FM et al (2010) Was wir nicht messen, detektieren wir meist auch nicht. AINS 45:106–111
S3-Leitlinie (2015) Analgesie, Sedierung und Delirmanagement in der Intensivmedizin. AWMF Register Nr.:001/012
Ely EW, Shintani A, Truman B et al (2004) Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 291:1753–1762
Pisani MA, Kong SY, Kasl SV et al (2009) Days of delirium are associated with 1‑year mortality in an older intensive care unit population. Am J Respir Crit Care Med 180:1092–1097
Pandharipande PP, Girard TD, Jackson JC et al (2013) Long-term cognitive impairment after critical illness. N Engl J Med 369:1306–1316
Levkoff S, Liptzin B, Cleary P et al (1996) Subsyndromal delirium. Am J Geriatr Psychiatry 4:320–329
Donovan AL, Aldrich M, Gross AK (2018) Interprofessional care and teamwork in the ICU. Crit Care Med 46:980–990
Jenewein J, Büchi S (2007) Neurobiologische und pathophysiologische Grundlagen des Delirs. Schweiz Arch Neurol Psychiatr 158:360–367
Fong TG, Tulebaev SR, Inouye SK (2009) Delirium in elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol 5:210–220
Trzepacz PT (2000) Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 5:132–148
Hilger E, Fischer P (2002) Pathophysiologische Korrelate deliranter Syndrome. J Neurol Neurochir Psychiatr 3:32–40
Von Haken R, Gruß M, Plaschke K et al (2010) Delir auf der Intensivstation. Anästhesist 59:235–247
Han , McCusker J, Cole M et al (2001) Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 161:1099–1105
Mulsant BH, Pollock BG, Kishner M et al (2003) Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 60:198–203
Calabresi P, Picconi B, Parnetti L et al (2006) A convergent model for cognitive dysfunctions in Parkinson’s disease: the critical dopamine-acetylcholine synaptic balance. Lancet Neurol 5:974–983
Van der Mast RC, Fekkes D (2000) serotonin and amino acids: partners in delirium pathophysiology? Semin Clin Neuropsychiatry 5:125–131
Pendlebury ST, Lovett NG, Smith SC et al (2015) Observational, longitudinal study of delirium in consecutive unselected acute medical admissions: age-specific rates and associated factors, mortality and re-admission. BMJ Open 5:e7808
Pandharipande P, Shintani A, Peterson J et al (2006) Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 1100:781–787
Kelly KM, Nadon NL, Morrison JH et al (2006) The neurobiology of aging. Epilepsy Res 68(Suppl.1):5–20
Inouye S, Zhang Y, Jones R et al (2007) Risk factors for delirium at discharge: development and validation of a predictive model. Arch Intern Med 167:1406–1413
Krabbe KS, Pedersen M, Bruunsgaard H (2004) Inflammatory mediators in the elderly. Exp Gerontol 39:687–699
Cerejeira J, Firmino H, Vaz-Serra A et al (2010) The neuroinflammatory hypothesis of delirium. Acta Neuropathol 119:737–754
de Rooji SE, van Munster BC, Korevaar JC et al (2007) Cytokines and acute phase response in delirium. J Psychosom Res 62:521–525
Beloosesky Y, Hendel D, Weiss A et al (2007) Cytokines and C‑reactive production in hip-fracture-operated elderly patients. J Gerontol 62:420–426
Uchikado H, Akiyama H, Kondo H et al (2004) Activation of vascular endothelial cells and perivascular cells by systemic inflammation – an immunohistochemical study of postmortem human brain tissues. Acta Neuropathol 107:341–351
Hshieh TT, Fong TG, Marcantonio ER et al (2008) Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci 63:764–772
Vendemiale G, Grattagliano I, Altomare E (1999) An update on the role of free radicals and antioxidant defense in human disease. Int J Clin Lab Res 29:49–55
Karlidag R, Unal S, Sezer OH et al (2006) The role of oxidative stress in postoperative delirium. Gen Hosp Psychiatry 28:418–423
Berr C, Balansard B, Arnaud J et al (2000) Cognitive decline is associated with systemic oxidative stress: the EVA study. J Am Geriatr Soc 48:1285–1291
Siesjo BK (1984) Cerebral circulation and metabolism. J Neurosurg 60:883–908
Gibson GE, Blass JP (1976) Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycemia. J Neurochem 27:37–42
Vyas S, Rodrigues AJ, Silva JM et al (2016) Chronic stress and glucocorticoids: from neuronal plasticity to neurodegeneration. Neural Plast 2016:6391686
Maclullich AM, Ferguson KJ, Miller T et al (2008) Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. J Psychosom Res 65:229–238
O’Keffe ST, Devlin JG (1994) Delirium and the dexamethasone suppression test in the elderly. Neuropsychobiology 30:153–156
McIntosh TK, Bush HL, Yeston NS et al (1985) Beta-endorphin, cortisol and postoperative delirium: a preliminary report. Psychoneuroendocrinology 10:303–313
McEwen BS, Bowles NP, Gray JD et al (2015) Mechanisms of stress in the brain. Nat Neurosci 18:1353–1363
Maldonado JR (2013) Neuropathogenesis of delirium: review of current etiologic theories and common pathways. Am J Geriatr Psychiatry 21:1190–1222
McEwen BS (2006) Sleep deprivation as a neurobiologic and physiologic stressor: allostasis and allostatic load. Metabolism 55:20–23
Mistraletti G, Carloni E, Cigada M et al (2008) Sleep and delirium in the intensive care unit. Minerva Anestesiol 74:329–333
Miyazaki T, Kuwano H, Kato H et al (2003) Correlation between serum melatonin circadian rhythm and intensive care unit psychosis after thoracic esophagectomy. Surgery 133:662–668
Chen S, Shi L, Liang F et al (2016) Exogenous melatonin for delirium prevention: a meta-analysis of randomized controlled trails. Mol Neurobiol 53:4046–4053
Reade MC, Finfer S (2014) Sedation and delirium in the intensive care unit. N Engl J Med 370:444–454
Morandi A, Piva S, Ely EW et al (2017) Worldwide survey of the „Assessing pain, both spontaneous awakening and breathing trials, choice of drugs, delirium monitoring/management, early exercise/mobility, and family empowerment“ (ABCDEF) Bundle. Crit Care Med 45:1111–1122
Barr J, Fraser GL, Puntillo K et al (2013) Clinical practice guidelines for the management of pain, agitation and delirium in adult patients in the intensive care unit. Crit Care Med 41:263–306
Pandharipande P, Cotton BA, Shintani A et al (2007) Motoric subtypes of delirium in mechanically ventilated surgical and trauma intensive care unit patients. Intensive Care Med 33:1726–1731
Luetz A, Balzer F, Radtke FM et al (2014) Delirium, sedation and analgesia in the intensive care unit: a multinational, two-part survey among intensivists. PLoS ONE 9:e110935
Plaschke K, Petersen KA, Frankenhauser S et al (2016) The impact of plasma cholinergic enzyme activity and other risk factors for the development of delirium in patients receiving palliative care. J Pain Symptom Manage 52:525–532
Luetz A, Heymann A, Radkte FM et al (2010) Different assessment tools for intensive care unit delirium: which score to use? Crit Care Med 38:409–418
Radkte FM, Franck M, Oppermann S et al (2009) Die Intensive Care Delirium Screening Checklist (ICDSC) Richtlinienkonforme Übersetzung und Validierung einer intensivmedizinischen Delirium-Checkliste. AINS 2:80–86
Khan BA, Perkins AJ, Gao S et al (2017) The confusion assessment method for the ICU-7 delirium severity scale: a novel delirium severity instrument for use in the ICU. Crit Care Med 45:851–857
Inouye SK, Bogardus ST, Charpentier PA et al (1999) A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340:669–676
Jablonski J, Gray J, Miano T et al (2017) Pain, agitation and delirium guidelines: Interprofessional perspectives to translate the evidence. Dimens Crit Care Nurs 36:164–173
Slatore CG, Hansen L, Ganzini L et al (2012) Communication by nurses in the intensive care unit: qualitative analysis of domains of patient-centered care. Am J Crit Care 21:410–418
Guo Y, Fan Y (2016) A preoperative, nurse-led intervention program reduces acute postoperative delirium. J Neurosci Nurs 48:229–235
Schweickert WD, Hall J (2007) ICU-acquired weakness. Chest 131:1541–1549
Schweickert WD, Pohlmann MC, Pohlmann AS et al (2009) Early physical and occupational therapy in mechanically ventilated, critical ill patients: a randomized controlled trail. Lancet 373:1874–1882
Inouye SK, Bogardus ST, Williams CS et al (2003) The role of adherence on the effectiveness of nonpharmacologic interventions. Arch Intern Med 163:958–964
Alberda C, Gramlich L, Jones N et al (2009) The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med 35:1728–1737
Zoremba N (2017) Delirmanagement in der Intensivmedizin – Nichtmedika-mentöse Therapieoptionen. Med Klein Intensivmed Notfmed 112:320–325
Luetz A, Weiss B, Penzel T et al (2016) Feasibility of noise reduction by a modification in ICU environment. Physiol Meas 37:1041–1055
Hu RF, Jiang XY, Hegadoren KM et al (2015) Effects of earplugs and eye masks combined with relaxing music on sleep, melatonin and cortisol levels in ICU patients: a randomized controlled trial. Crit Care 19:115
Czaplik M, Rossaint R, Kaliciak J et al (2016) Psychoacoustic analysis of noise and the application of earplugs in an ICU: a randomized controlled clinical trial. Eur J Anaesthesiol 33:14–21
Patel J, Baldwin J, Bunting P et al (2014) The effect of a multicomponent multidisciplinary bundle of interventions on sleep and delirium in medical and surgical intensive care patients. Anaesthesia 69:540–549
Böhm S (2012) Cholinerge Systeme. In: Freissmuth M (Hrsg) Pharmakologie und Toxikologie. Springer, Heidelberg
Pandharipande P, Shintani A, Peterson J et al (2006) Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 104:21–26
Louzon P, Jennings H, Ali M et al (2017) Impact of pharmacist management of pain, agitation, and delirium in the intensive care unit through participation in multidisciplinary bundle rounds. Am J Health Syst Pharm 74:253–262
Siddiqi N, Harrison JK, Clegg A et al (2016) Interventions for preventing delirium in hospitalized non ICU-patients. Cochrane Database Syst Rev 3:CD5563
Van den Bloogaard M, Slooter AJC, Brüggemann RJM et al (2018) Effect of haloperidol on survival among critically ill adults with a high risk of delirium: The REDUCE randomized clinical trial. JAMA 319:680–690
Chen S, Shi L, Liang F et al (2016) Endogenous melatonin for delirium prevention: a meta-analysis of randomized controlled trails. Mol Neurobiol 53:4046–4053
Su X, Meng ZT, Wu XH et al (2016) Demedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomized, double-blind, placebo-controlled trail. Lancet 388:1893–1902
Skrobik Y, Duprey MS, Hill NS et al (2018) low-dose nocturnal dexmedetomidine prevents ICU delirium: a randomized, placebo-controlled trail. Am J Respir Crit Care Med. https://doi.org/10.1164/rccm.201710-1995OC
Duan X, Coburn M, Rossaint R et al (2018) Efficacy of perioperative dexmedetomidine on postoperative delirium: systematic review and meta-analysis with trial sequential analysis of randomised controlled trials. Br J Anaesth 121:384–397
Shelton KT, Qu J, Bilotta F et al (2018) Minimizing ICU neurological dysfunction with dexmedetomidine-induced sleep (MINDDS): protocol for a randomised, double-blind, parallel-arm, placebo-controlled trial. BMJ Open 8:e20316
Barr J, Pandharipande PP (2013) The pain, agitation, and delirium care bundle: synergistic benefits of implementing the 2013 pain, agitation, and delirium guidelines in an integrated and interdisciplinary fashion. Crit Care Med 41:99–115
Reade MC, Eastwood GM, Bellomo R et al (2016) Effect of dexmede-tomidine added to standard care on ventilator-free time in patients with agitated delirium: a randomized clinical trail. JAMA 315:1460–1468
Lonergan E, Luxenberg J, Areosa Sastre A (2009) Benzodiazepines for delirium. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD6379
Lonergan E, Britton AM, Luxenberg J et al (2007) Antipsychotics for delirium. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD5594
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
N. Zoremba, M. Coburn und G. Schälte geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Zoremba, N., Coburn, M. & Schälte, G. Delir beim Intensivpatienten. Anaesthesist 67, 811–820 (2018). https://doi.org/10.1007/s00101-018-0497-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00101-018-0497-3